CSS
DARE icon

Cubist Systematic Strategies’s Dare Bioscience DARE Stock Holding History

Cubist Systematic Strategies’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,403
Closed -$21K – 4472
2022
Q2 		$21K Buy
+1,403
New +$21.1K ﹤0.01% 4214
2022
Q1 		– Sell
-6,443
Closed -$155K – 3597
2021
Q4 		$155K Buy
+6,443
New +$133K ﹤0.01% 3105

Other funds holding DARE

FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cubist Systematic Strategies's DARE Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of Dare Bioscience (DARE) in Q3 2022, closing a stake of 1,403 shares — an estimated $21K sold.

Cubist Systematic Strategies first reported a position in DARE in Q4 2021 and held it in 2 quarters. The position peaked at $155K in Q4 2021. 31 funds tracked by Wall St. Rank hold DARE as of Q3 2022.

  • Cubist Systematic Strategies reported no remaining Dare Bioscience position as of Q3 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,403 Dare Bioscience shares in Q3 2022, an estimated $21K.
  • Cubist Systematic Strategies first reported a position in Dare Bioscience in Q4 2021 and held it in 2 quarters.
  • Cubist Systematic Strategies's Dare Bioscience position peaked at $155K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.